7LUS image
Deposition Date 2021-02-23
Release Date 2021-09-15
Last Version Date 2024-11-20
Entry Detail
PDB ID:
7LUS
Keywords:
Title:
IgG2 Fc Charge Pair Mutation version 1 (CPMv1)
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.45 Å
R-Value Free:
0.23
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 61
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Immunoglobulin heavy constant gamma 2
Gene (Uniprot):IGHG2
Mutations:E356K, D399K
Chain IDs:B (auth: A)
Chain Length:208
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Immunoglobulin heavy constant gamma 2
Gene (Uniprot):IGHG2
Mutations:K392D, K409D
Chain IDs:A (auth: B)
Chain Length:207
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Next generation Fc scaffold for multispecific antibodies.
Iscience 24 103447 103447 (2021)
PMID: 34877503 DOI: 10.1016/j.isci.2021.103447

Abstact

Bispecific antibodies (Bispecifics) demonstrate exceptional clinical potential to address some of the most complex diseases. However, Bispecific production in a single cell often requires the correct pairing of multiple polypeptide chains for desired assembly. This is a considerable hurdle that hinders the development of many immunoglobulin G (IgG)-like bispecific formats. Our approach focuses on the rational engineering of charged residues to facilitate the chain pairing of distinct heavy chains (HC). Here, we deploy structure-guided protein design to engineer charge pair mutations (CPMs) placed in the CH3-CH3' interface of the fragment crystallizable (Fc) region of an antibody (Ab) to correctly steer heavy chain pairing. When used in combination with our stable effector functionless 2 (SEFL2.2) technology, we observed high pairing efficiency without significant losses in expression yields. Furthermore, we investigate the relationship between CPMs and the sequence diversity in the parental antibodies, proposing a rational strategy to deploy these engineering technologies.

Legend

Protein

Chemical

Disease

Primary Citation of related structures